Herceptin

Latest stories

5d
FOX Business
Forget Sarepta Therapeutics, Here Are 3 Other Biotech Stocks To Buyfor the extended adjuvant treatment of patients with early-stage HER2+ breast c
Forget Sarepta Therapeutics, Here Are 3 Other Biotech Stocks To Buy
FOX Business / Posted 5 days ago
for the extended adjuvant treatment of patients with early-stage HER2+ breast cancer who have been previously treated with Herceptin to delay the recurrence of their cancer. In trials, neratinib patients saw a 33% reduction of risk of invasive... Read more
3 related stories
5d
FOX Business
Forget Sarepta Therapeutics, Here Are 3 Other Biotech Stocks To Buyfor the extended adjuvant treatment of patients with early-stage HER2+ breast c
Forget Sarepta Therapeutics, Here Are 3 Other Biotech Stocks To Buy
FOX Business / Posted 5 days ago
for the extended adjuvant treatment of patients with early-stage HER2+ breast cancer who have been previously treated with Herceptin to delay the recurrence of their cancer. In trials, neratinib patients saw a 33% reduction of risk of invasive... Read more
3 related stories
5d
Business Wire
Puma Biotechnology Announces U.S. FDA Acceptance of New Drug Application for PB272 (Neratinib) for Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancerof patients with early stage HER2-overexpressed/amplified breast cancer who hav
Puma Biotechnology Announces U.S. FDA Acceptance of New Drug Application for PB272 (Neratinib) for Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer
Business Wire / Posted 5 days ago
of patients with early stage HER2-overexpressed/amplified breast cancer who have received prior adjuvant trastuzumab (Herceptin®)-based therapy. “The FDA acceptance of our NDA is an important regulatory milestone,” said Alan H. Auerbach,... Read more
5d
Business Wire
US Breast Cancer Drug Market Outlook 2022monoclonal antibodies due to superior pharmacological effects and availability
US Breast Cancer Drug Market Outlook 2022
Business Wire / Posted 5 days ago
monoclonal antibodies due to superior pharmacological effects and availability of large number of products in this segment. Herceptin (Trastuzumab monoclonal antibody) is commonly prescribed breast cancer medicine. Roche developed Pertuzumab... Read more
6d
Reuters
GE brings off-the-shelf biotech drug factories to Irelandinjectable medicines like AbbVie's (ABBV.N) Humira for rheumatoid arthritis and
GE brings off-the-shelf biotech drug factories to Ireland
Reuters / Posted 6 days ago
injectable medicines like AbbVie's (ABBV.N) Humira for rheumatoid arthritis and Roche's (ROG.S) breast cancer treatment Herceptin. KUBio factories offer GE a way to build up its presence in biotech medicine, which it sees as a central plank of... Read more
6d
ScienceBlogs
Can the Cancer Moonshot do what its advocates promise?that have been developed. For example, there are humanized monoclonal antibodie
Can the Cancer Moonshot do what its advocates promise?
ScienceBlogs / Posted 6 days ago
that have been developed. For example, there are humanized monoclonal antibodies against specific cancer targets (like Herceptin), which are more targeted therapy than immunotherapy per se. There are cell-based therapies, some of which I saw... Read more
3 related stories
6d
Fortune
GE Digs Deeper Into Biotech with New Irish Factorieson top-selling injectable medicines like AbbVie’s Humira for rheumatoid arthrit
GE Digs Deeper Into Biotech with New Irish Factories
Fortune / Posted 6 days ago
on top-selling injectable medicines like AbbVie’s Humira for rheumatoid arthritis and Roche’s breast cancer treatment Herceptin. KUBio factories offer GE a way to build up its presence in biotech medicine, which it sees as a central plank of... Read more
7d
Bangor Daily News
Pink-clad Komen warriors race, walk toward cure for breast canceralso wear the team’s T-shirts in support of the cause. “I completed the chemo
Pink-clad Komen warriors race, walk toward cure for breast cancer
Bangor Daily News / Posted 7 days ago
also wear the team’s T-shirts in support of the cause. “I completed the chemo in April but I’m still having infusions of Herceptin, which targets the gene that makes my cancer more aggressive,” said Jones, who works at St. Joseph Hospital. “I’ll... Read more
10d
The Times & The Sunday Times
Cost of new drugs 'soars'commitment was needed. One of the panel's chief concerns was the high cost of
Cost of new drugs 'soars'
The Times & The Sunday Times / Posted 10 days ago
commitment was needed. One of the panel's chief concerns was the high cost of new drugs. In South Africa a course of Herceptin, a drug used to treat breast cancer, costs R500000, but many medical aids refuse to pay for it and it is not... Read more
15d
The New Zealand Herald
'How do you eat an elephant?'(left breast mastectomy and tram flap reconstruction), six chemotherapy infusio
'How do you eat an elephant?'
The New Zealand Herald / Posted 15 days ago
(left breast mastectomy and tram flap reconstruction), six chemotherapy infusions, 25 radio­therapy treatments, 17 Herceptin ­infusions, one nipple reconstruction and nipple/­areola tattoo and 2958 ­Tamoxifen ­tablets (692 more to go). I... Read more
16d
Morningstar
Drug Pricing Power Transcends PoliticsRoche's pharmaceutical division, blockbuster cancer biologics acquired with Gen
Drug Pricing Power Transcends Politics
Morningstar / Posted 16 days ago
Roche's pharmaceutical division, blockbuster cancer biologics acquired with Genentech--including Avastin, Rituxan, and Herceptin--continue to grow quickly as they gain market share in approved indications and garner widened approval in new... Read more
18d
FOX Business
This Expected News Sent PDL BioPharma Inc. Down 17% in Augustportfolio, which predominantly expired in December 2014. PDL's intellectual pro
This Expected News Sent PDL BioPharma Inc. Down 17% in August
FOX Business / Posted 18 days ago
portfolio, which predominantly expired in December 2014. PDL's intellectual property is found in blockbuster drugs like Herceptin, Avastin, and Tysabri. PDL's revenue didn't fall off a cliff immediately because management had cautioned that it... Read more
18d
FOX Business
This Expected News Sent PDL BioPharma Inc. Down 17% in Augustportfolio, which predominantly expired in December 2014. PDL's intellectual pro
This Expected News Sent PDL BioPharma Inc. Down 17% in August
FOX Business / Posted 18 days ago
portfolio, which predominantly expired in December 2014. PDL's intellectual property is found in blockbuster drugs like Herceptin, Avastin, and Tysabri. PDL's revenue didn't fall off a cliff immediately because management had cautioned that it... Read more
18d
FOX Business
3 Terrible Stocks for RetireesPDL's lifeblood has been its Queen patent portfolio. These patents can be found
3 Terrible Stocks for Retirees
FOX Business / Posted 18 days ago
PDL's lifeblood has been its Queen patent portfolio. These patents can be found in blockbuster therapies like Avastin, Herceptin, Lucentis, and Tysabri. Here's the issue: PDL's Queen patents expired in December 2014. The good news for the... Read more
18d
FOX Business
3 Terrible Stocks for RetireesPDL's lifeblood has been its Queen patent portfolio. These patents can be found
3 Terrible Stocks for Retirees
FOX Business / Posted 18 days ago
PDL's lifeblood has been its Queen patent portfolio. These patents can be found in blockbuster therapies like Avastin, Herceptin, Lucentis, and Tysabri. Here's the issue: PDL's Queen patents expired in December 2014. The good news for the... Read more
18d
Morningstar
Looking for Bargains? Check Out High-Quality Healthcare Stockssegment, Andersen points out that blockbuster cancer biologics acquired with Ge
Looking for Bargains? Check Out High-Quality Healthcare Stocks
Morningstar / Posted 18 days ago
segment, Andersen points out that blockbuster cancer biologics acquired with Genentech--including Avastin, Rituxan, and Herceptin--continue to grow quickly as they gain market share in approved indications, and they have also gained approval in... Read more
24d
FOX News
Regulators pave way for biosimilar drug breakthroughbiosimilar versions of Remicade is also likely increase the perceived risk for
Regulators pave way for biosimilar drug breakthrough
FOX News / Posted 24 days ago
biosimilar versions of Remicade is also likely increase the perceived risk for Roche's top-selling cancer drugs Rituxan and Herceptin. Roche is trying to protect its existing products by bringing out improved, patented versions of its... Read more
8 related stories
27d
Morningstar
Allergan Still Undervaluedregulatory, and marketing hurdles. The partnership includes biosimilar versions
Allergan Still Undervalued
Morningstar / Posted 27 days ago
regulatory, and marketing hurdles. The partnership includes biosimilar versions of Erbitux, Rituxan, Avastin, and Herceptin. Industry Leader in Specialty Markets We think Allergan possesses a wide economic moat. Management’s recent... Read more

People in this news